Nifty

:

23346.40

Sensex

:

74294.96

75.80 (0.33%)
-19.63 (-0.03%)

Login

Nifty
Sensex

:
:

23346.40
74294.96

75.80 (0.33%)
-19.63 (-0.03%)

Novartis India Ltd.

Pharmaceuticals & Drugs - Domestic

Rating :

72/99

BSE: 500672 | NSE: NOVARTIND

Watchlist

NSE BSE

2046.80

18-Sep-2026

Open
High
Low
Previous Close

2082.2
2154.9
2006
2082.20

Volume
Traded Value (lacs)
52 Week High
52 Week Low

76794
159620136
2588.8
950

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

5,080.13
51.96
5

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

4,412.43
N/A
5.98

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

-5.98
-2.39
1.88

EBITDA CAGR (%)

10 Years
5 Years
3 Years

14.39
28.60
7.59

PAT CAGR (%)

10 Years
5 Years
3 Years

5.00
-
3.03

P:E (Median)

8 Years
5 Years
3 Years

30.62
26.68
25.22

P:BV (Average)

8 Years
5 Years
3 Years

2.72
2.86
3.21

EV:EBITDA (Average)

8 Years
5 Years
3 Years

14.46
14.51
14.55

Earnings Forecasts:

(Updated: 19-09-2026)

Description 2026 2027 2028 2029
Adj EPS 54 -9 - -
P/E Ratio 37.90 -227.42 - -
Revenue - - - -
EBITDA - - - -
Net Income - - - -
ROA - - - -
P/B Ratio - - - -
ROE - - - -
FCFF - - - -
FCFF Yield - - - -
Net Debt - - - -
BVPS - - - -

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Jun 26 Jun 25 Var% Mar 26 Mar 25 Var% Dec 25 Dec 24 Var% Sep 25 Sep 24 Var%
Net Sales 103.81 87.55 18.57% 90.55 83.88 7.95% 85.90 93.00 -7.63% 90.33 87.10 3.71%
Expenses 68.90 60.31 14.24% 69.93 59.97 16.61% 63.54 67.42 -5.75% 66.45 69.14 -3.89%
EBITDA 34.91 27.24 28.16% 20.62 23.91 -13.76% 22.36 25.58 -12.59% 23.88 17.96 32.96%
EBIDTM 33.63% 31.11% 22.77% 28.50% 26.03% 27.51% 26.44% 20.62%
Other Income 8.74 10.61 -17.62% 10.01 10.63 -5.83% 8.75 10.60 -17.45% 9.40 10.32 -8.91%
Interest 0.06 0.10 -40.00% 0.07 0.12 -41.67% 0.98 0.36 172.22% 0.11 0.14 -21.43%
Depreciation 0.42 0.53 -20.75% 0.42 0.53 -20.75% 0.48 0.53 -9.43% 0.52 0.58 -10.34%
PBT 43.17 37.22 15.99% 30.14 33.89 -11.07% 29.65 35.29 -15.98% 32.65 27.56 18.47%
Tax 10.96 9.60 14.17% 4.89 4.59 6.54% 13.56 9.84 37.80% 8.43 7.15 17.90%
PAT 32.21 27.62 16.62% 25.25 29.30 -13.82% 16.09 25.45 -36.78% 24.22 20.41 18.67%
PATM 31.03% 31.55% 27.89% 34.93% 18.73% 27.37% 26.81% 23.43%
EPS 13.04 11.18 16.64% 10.22 11.86 -13.83% 6.51 10.30 -36.80% 9.81 8.26 18.77%

Description Mar 26 Mar 25 Var% Dec 25 Dec 24 Var% Sep 25 Sep 24 Var% Jun 25 Jun 24 Var%
Net Sales 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Right to Left

Description TTM Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Net Sales 370.59 354.33 356.27 335.07 378.74 399.87 381.35 438.25 490.68 563.89 656.22 Net Sales Growth 5.42% -0.54% 6.33% -11.53% -5.28% 4.86% -12.98% -10.69% -12.98% -14.07% Cost Of Goods Sold 207.27 198.37 202.82 199.84 201.69 178.14 146.61 182.32 198.65 245.51 306.10 Gross Profit 163.32 155.96 153.45 135.23 177.05 221.73 234.74 255.93 292.03 318.38 350.12 GP Margin 44.07% 44.02% 43.07% 40.36% 46.75% 55.45% 61.56% 58.40% 59.52% 56.46% 53.35% Total Expenditure 268.82 260.23 264.85 269.81 313.66 373.12 355.66 426.51 478.54 572.12 631.70 Power & Fuel Cost - 0.11 0.14 0.18 0.35 0.53 0.53 1.27 1.79 2.56 1.77 % Of Sales - 0.03% 0.04% 0.05% 0.09% 0.13% 0.14% 0.29% 0.36% 0.45% 0.27% Employee Cost - 21.08 18.72 22.96 35.64 101.89 108.51 113.87 117.11 144.53 139.30 % Of Sales - 5.95% 5.25% 6.85% 9.41% 25.48% 28.45% 25.98% 23.87% 25.63% 21.23% Manufacturing Exp. - 12.09 11.08 7.54 15.51 34.49 36.52 39.23 42.21 42.07 49.03 % Of Sales - 3.41% 3.11% 2.25% 4.10% 8.63% 9.58% 8.95% 8.60% 7.46% 7.47% General & Admin Exp. - 10.35 12.44 15.37 17.09 18.61 12.95 23.40 43.28 45.74 45.74 % Of Sales - 2.92% 3.49% 4.59% 4.51% 4.65% 3.40% 5.34% 8.82% 8.11% 6.97% Selling & Distn. Exp. - 11.91 10.58 15.87 27.98 35.66 39.77 53.99 60.29 72.48 75.83 % Of Sales - 3.36% 2.97% 4.74% 7.39% 8.92% 10.43% 12.32% 12.29% 12.85% 11.56% Miscellaneous Exp. - 6.32 9.07 8.05 15.40 3.80 10.77 12.43 15.21 19.23 75.83 % Of Sales - 1.78% 2.55% 2.40% 4.07% 0.95% 2.82% 2.84% 3.10% 3.41% 2.12% EBITDA 101.77 94.10 91.42 65.26 65.08 26.75 25.69 11.74 12.14 -8.23 24.52 EBITDA Margin 27.46% 26.56% 25.66% 19.48% 17.18% 6.69% 6.74% 2.68% 2.47% -1.46% 3.74% Other Income 36.90 38.77 41.96 61.68 58.11 33.55 34.19 36.43 78.40 173.81 71.52 Interest 1.22 1.26 0.77 1.49 1.75 4.83 7.68 6.39 1.59 5.53 0.72 Depreciation 1.84 1.95 2.19 2.61 6.06 9.65 12.16 13.14 3.18 2.53 3.59 PBT 135.61 129.66 130.42 122.84 115.38 45.82 40.04 28.64 85.77 157.52 91.73 Tax 37.84 36.48 29.52 37.65 12.02 -0.10 19.14 18.56 34.00 79.16 34.51 Tax Rate 27.90% 28.14% 22.63% 30.65% 10.42% 2.62% 47.80% 64.80% 39.64% 50.25% 37.62% PAT 97.77 93.18 100.90 85.19 103.36 -3.72 20.90 10.08 51.77 78.36 57.22 PAT before Minority Interest 97.77 93.18 100.90 85.19 103.36 -3.72 20.90 10.08 51.77 78.36 57.22 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 26.38% 26.30% 28.32% 25.42% 27.29% -0.93% 5.48% 2.30% 10.55% 13.90% 8.72% PAT Growth -4.87% -7.65% 18.44% -17.58% - - 107.34% -80.53% -33.93% 36.95% EPS 39.58 37.72 40.85 34.49 41.85 -1.51 8.46 4.08 20.96 31.72 23.17

Results Balance Sheet

Standalone Figures in Rs. Crores

Right to Left

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Shareholder's Funds 817.83 784.96 744.82 775.66 691.70 711.19 720.73 759.19 733.64 919.64 Share Capital 12.34 12.34 12.34 12.34 12.34 12.34 12.34 12.34 12.34 14.07 Total Reserves 805.49 772.62 732.48 763.36 681.58 701.80 711.68 751.10 727.48 913.00 Non-Current Liabilities 724.89 696.83 716.25 1,007.77 984.00 1,130.65 99.38 891.47 897.75 827.53 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 736.64 708.90 726.33 998.39 991.58 1,109.57 65.93 909.70 916.30 844.46 Current Liabilities 430.61 426.12 399.83 268.26 334.47 357.26 416.93 367.22 481.74 323.21 Trade Payables 54.65 51.47 61.59 59.67 72.20 55.20 72.60 91.40 106.11 73.22 Other Current Liabilities 23.94 24.83 33.54 38.03 45.34 69.64 132.99 67.62 184.52 63.26 Short Term Borrowings 0.00 0.00 0.02 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Short Term Provisions 352.02 349.82 304.68 170.56 216.93 232.42 211.34 208.20 191.11 186.73 Total Liabilities 1,973.33 1,907.91 1,860.90 2,051.69 2,010.17 2,199.10 1,237.04 2,017.88 2,113.13 2,070.38 Net Block 2.88 4.54 6.94 19.25 23.65 63.91 76.28 14.98 4.60 5.71 Gross Block 9.37 9.08 28.36 38.92 40.71 74.81 85.08 23.93 12.09 10.82 Accumulated Depreciation 6.49 4.54 21.42 19.67 17.06 10.90 8.80 8.95 7.49 5.11 Non Current Assets 919.44 878.02 919.01 1,265.59 1,183.39 1,276.75 239.77 1,029.20 1,008.86 958.91 Capital Work in Progress 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 Non Current Investment 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 910.78 870.18 903.63 1,240.75 1,148.65 1,186.01 137.84 989.61 979.98 935.98 Other Non Current Assets 5.78 3.30 8.44 5.59 11.09 26.83 25.65 24.61 24.28 17.21 Current Assets 1,053.89 1,029.89 941.89 786.06 825.87 922.35 997.27 988.68 1,104.27 1,111.47 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 53.32 41.11 44.86 54.72 57.07 47.95 58.68 60.51 56.56 87.52 Sundry Debtors 37.05 40.14 41.47 36.16 44.56 38.73 37.60 45.59 43.91 40.83 Cash & Bank 667.70 648.03 596.08 555.94 517.63 498.88 581.91 612.02 775.08 815.72 Other Current Assets 295.82 2.47 2.04 15.95 206.61 336.79 319.08 270.56 228.72 167.40 Short Term Loans & Adv. 292.77 298.14 257.44 123.29 191.12 290.49 259.99 236.02 202.29 146.86 Net Current Assets 623.28 603.77 542.06 517.80 491.40 565.09 580.34 621.46 622.53 788.26 Total Assets 1,973.33 1,907.91 1,860.90 2,051.65 2,009.26 2,199.10 1,237.04 2,017.88 2,113.13 2,070.38

Cash Flow

Standalone Figures in Rs. Crores

Right to Left

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Cash From Operating Activity 46.73 74.57 113.40 44.80 38.67 -69.21 -23.14 -194.28 160.99 -40.83 PBT 129.66 130.42 122.84 115.38 -3.82 40.04 28.64 85.77 157.52 91.73 Adjustment -33.76 -38.80 -56.75 -48.92 -5.64 -4.98 -11.80 -72.66 -55.87 -55.95 Changes in Working Capital -13.91 -0.76 9.04 -24.00 66.72 -69.08 -1.85 -161.76 117.30 -32.45 Cash after chg. in Working capital 81.99 90.86 75.13 42.46 57.26 -34.02 14.99 -148.65 218.95 3.33 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -35.26 -16.29 38.27 2.34 -18.59 -35.19 -38.13 -45.63 -57.96 -44.16 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity 17.63 -3.31 33.13 -153.25 87.04 95.16 55.91 274.23 68.70 423.64 Net Fixed Assets -0.29 19.28 10.56 1.79 34.10 10.27 -61.15 -11.84 -1.26 -0.51 Net Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Others 17.92 -22.59 22.57 -155.04 52.94 84.89 117.06 286.07 69.96 424.15 Cash from Financing Activity -63.93 -64.15 -120.99 -30.48 -35.63 -36.80 -41.41 -29.82 -267.65 -331.80 Net Cash Inflow / Outflow 0.43 7.11 25.54 -138.93 90.08 -10.85 -8.64 50.13 -37.96 51.01 Opening Cash & Equivalents 52.07 44.96 19.42 158.35 68.27 79.12 87.76 37.63 75.59 24.58 Closing Cash & Equivalent 52.50 52.07 44.96 19.42 158.35 68.27 79.12 87.76 37.63 75.59

Financial Ratios

Standalone

Right to Left

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Book Value (Rs.) 331.37 318.06 301.79 314.30 281.17 289.36 293.36 309.34 299.76 329.45 ROA 4.80% 5.35% 4.35% 5.09% -0.18% 1.22% 0.62% 2.51% 3.75% 3.27% ROE 11.63% 13.19% 11.21% 14.07% -0.53% 2.91% 1.36% 6.89% 9.40% 5.38% ROCE 16.34% 17.15% 16.35% 15.96% 0.14% 6.67% 4.73% 11.70% 19.72% 8.75% Fixed Asset Turnover 40.86 20.84 10.90 10.39 8.43 5.68 9.77 32.72 59.76 63.43 Receivable days 37.37 38.18 38.62 35.62 31.23 30.70 28.50 27.72 22.59 25.31 Inventory Days 45.72 40.22 49.54 49.34 39.38 42.89 40.83 36.25 38.41 44.47 Payable days 97.63 101.73 110.74 119.32 130.52 159.09 74.34 84.28 68.27 44.09 Cash Conversion Cycle -14.54 -23.33 -22.58 -34.36 -59.90 -85.49 -5.01 -20.31 -7.27 25.70 Total Debt/Equity 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Interest Cover 103.90 170.38 83.44 66.93 0.21 6.21 5.48 54.94 29.48 128.40

Top Investors:

investor education and protection fund (iepf)

Annual Reports:

News Update:

Novartis India - Quarterly Results
24th Jul 2026, 00:00 AM

Read More
Novartis India launches precision radiotherapy ‘Pluvicto’ for prostate cancer
15th Jun 2026, 15:59 PM

Pluvicto is the country's first regulatory authority-approved radioligand therapy for PSMA -positive prostate cancer
Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback